Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Terminated 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 12Breast 7Sarcoma 5Gastrointestinal 4Gynecologic 3Other hematologic neoplasm 2Thoracic 1Plasma cell 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Thyroid Neoplasms 1

Interventions

Cisplatin 28toripalimab 14Radiotherapy 12Gemcitabine 12Capecitabine 11Radiotherapy, Intensity-Modulated 10pembrolizumab 9Surgical Procedures, Operative 9Docetaxel 9tislelizumab 8Carboplatin 7Drug Therapy 6Blood Specimen Collection 6anlotinib 5Taxes 5Paclitaxel 5Nivolumab 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cetuximab 5Thyroxine 4Cyclophosphamide 4130-nm albumin-bound paclitaxel 4trametinib 3sintilimab 3camrelizumab 3Specimen Handling 3Radiation 3Observation 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Doxorubicin × Head & Neck × Clear all
NCT06713057 2024-12-03

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

West China Hospital

Phase 2 Not yet recruiting
20 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡